Search

everythinglearnresearchcommunity

for

Search:↓

Obese women with PCOS are more likely to have fatty liver disease.

People with androgenetic alopecia are more likely to have metabolic syndrome.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

Eating apples can help prevent heart disease, cancer, and other conditions because they have healthy plant chemicals.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

Tofacitinib is an effective and safe treatment for alopecia areata.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Hormonal imbalances, not insulin resistance or dyslipidemia, may be more important in causing acne in women over 25.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Many women with PCOS in Saudi Arabia suffer from depression and anxiety.

Cinnamon may help manage obesity and improve conditions related to Polycystic Ovary Syndrome (PCOS).

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Women with PCOS may have higher bad cholesterol and are at risk for blood sugar issues; lifestyle changes are recommended.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

The new rodent model successfully mimics non-lean human PCOS symptoms.

People with male pattern baldness are more likely to have metabolic syndrome.

Men can have genetic risks for PCOS-related traits like obesity and diabetes.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

The method can measure vitamin B3 levels in human hair accurately.